Advertisement

Topics

Galapagos finds a Partner to Boost its Pipeline with Drug Combinations

07:59 EST 10 Mar 2017 | Labiotech.eu

Galapagos and Pharnext will work together to develop low-dose drug combinations that improve drug efficacy and target new indications.  Galapagos, the biggest biotech in Belgium, has closed an R&D agreement with the French Pharnext to develop drug combinations of the billion-euro ...

This awesome article Galapagos finds a Partner to Boost its Pipeline with Drug Combinations appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Galapagos finds a Partner to Boost its Pipeline with Drug Combinations

NEXT ARTICLE

More From BioPortfolio on "Galapagos finds a Partner to Boost its Pipeline with Drug Combinations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...